US2014364629A1PendingUtilityA1
Microbial production of 3,4-dihydroxybutyrate (3,4-dhba), 2,3- dihydroxybutyrate (2,3-dhba) and 3-hydroxybutyrolactone (3-hbl)
Assignee: MASSACHUSETTS INST TECHNOLOGYPriority: Feb 25, 2011Filed: Mar 5, 2014Published: Dec 11, 2014
Est. expiryFeb 25, 2031(~4.6 yrs left)· nominal 20-yr term from priority
C12P 17/04C07D 307/33C07C 59/10C12N 15/70C12P 7/42C12N 15/52C12P 7/52
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to recombinant cells and their use in the production of 3,4-dihydroxybutyrate, 2,3-dihydroxybutyrate and 3-hydroxybutyrolactone.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 .- 31 . (canceled)
32 . A method for producing 3,4-dihydroxybutyrate (3,4-DHBA), 2,3-dihydroxybutyrate (2,3-DHBA) and/or 3-hydroxybutyrolactone (3-HBL) in a cell, comprising:
increasing the expression of a ycdW gene, an aceA gene, and an aceK gene in the cell, relative to a wild type cell, through an overexpression system; expressing a pct gene, at least one of a phaA, thil, atoB or bktB gene, and at least one of a phaB or hbd gene in the cell, through a heterologous expression system; and culturing the cell in minimal medium supplemented with a carbon source.
33 . The method of claim 32 , wherein the cell further recombinantly expresses a tesB gene.
34 . The method of claim 32 , wherein the cell is a bacterial cell, a fungal cell (including a yeast cell), a plant cell, an insect cell or an animal cell.
35 . The method of claim 34 , wherein the cell is a bacterial cell.
36 . The method of claim 35 , wherein the bacterial cell is an Escherichia coli cell.
37 . The method of claim 32 , wherein the cell endogenously expresses ycdW, aceA, and/or aceK, and wherein endogenous expression of ycdW, aceA, and/or aceK is increased through modification of the gene(s) and/or their promoter(s) and/or their ribosome binding sites (RBSs).
38 . The method of claim 32 , wherein one or more of ycdW, aceA, aceK, pct, phaA, thil, atoB, bktB, phaB and hbd are expressed from a plasmid, or wherein one or more copies of ycdW, aceA, aceK, pct, phaA, thil, atoB, bktB, phaB and hbd are integrated into the genome of the cell.
39 .- 41 . (canceled)
42 . The method of claim 32 , wherein the ycdW, aceA and/or aceK gene(s) is an Escherichia coli gene.
43 . (canceled)
44 . The method of claim 32 , wherein the phaA, bktB and/or phaB gene(s) is a Ralstonia eutropha gene.
45 . (canceled)
46 . The method of claim 32 , wherein the pct gene is a Megasphaera elsdenii gene.
47 . (canceled)
48 . The method of claim 33 , wherein the tesB gene is an Escherichia coli gene.
49 . (canceled)
50 . The method of claim 32 , wherein the carbon source comprises or consists of glucose.
51 . The method of claim 32 , wherein the carbon source comprises or consists of glycerol.
52 . The method of claim 32 , further comprising recovering the 3,4-DHBA, 2,3-DHBA and/or 3-HBL from the cell culture.
53 . A cell culture produced by the method of claim 32 .
54 . The cell culture of claim 53 , wherein the cell culture contains at least 0.1 g L −1 DHBA, at least 10 mg L −1 3-HBL or at least 0.1 g L-1 2,3-DHBA.
55 . (canceled)
56 . A supernatant of a cell culture produced by the method of claim 32 .
57 . The supernatant of claim 56 , wherein the supernatant is subjected to lactonization, optionally wherein lactonization is achieved through acidification to reduce the pH of the supernatant.
58 . (canceled)
59 . (canceled)
60 . A method comprising:
recombinantly expressing a pct gene, at least one of a phaA, thil, atoB or bktB gene, and at least one of a phaB or hbd gene in a cell that overexpresses a ycdW gene, an aceA gene, and an aceK gene.
61 . The method of claim 32 , wherein the cell has decreased or eliminated expression of an iclR gene, an aceB gene and a gcl gene, relative to a wild type cell.Join the waitlist — get patent alerts
Track US2014364629A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.